When Breast Cancer Screening Guidelines Disagree, Who Explains It to the Patient? | Breast Cancer Awareness Month 2026 | Day 07
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
When Breast Cancer Screening Guidelines Disagree, Who Explains It to the Patient? | Breast Cancer Awareness Month 2026 | Day 07
-
ナレーター：
-
著者：
A special BINA Voices edition!
October is Breast Cancer Awareness Month, and for the next 31 days, we are going beyond awareness to look at what happens after the mammogram.
Join Richard Lippert, Founder, President, and Chief Executive Auditor of Mammologix, as we carry on into Day 07 of our Breast Cancer Awareness Month 2026 series:
When Breast Cancer Screening Guidelines Disagree, Who Explains It to the Patient?
A result can be generated. A letter can be sent. A recommendation can be documented.
But the real question is: Did the patient complete the next step, and do we know the outcome?
This episode looks at what happens when USPSTF, ACOG, ACR, ACS, and ACP recommendations do not line up perfectly, and how breast imaging programs should respond.
A patient should never be expected to sort through competing national guidelines on her own.
Read the full article on LinkedIn here: https://www.linkedin.com/pulse/when-breast-cancer-screening-guidelines-disagree-who-explains-yqiwe/